JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY SCISCIE

中文简介

《抗菌药物化疗杂志》是国际上最重要的抗菌药物研究期刊之一。我们的读者包括学术界、工业界和卫生服务部门的代表，也包括那些在制定决策方面有影响力的人。该杂志每月出版一期，刊载有关实验室方面和抗菌药物临床应用的原创文章，包括抗菌、抗病毒、抗真菌和抗原性药物。除了丰富的初级论文外，该杂志还刊载评论文章，就当前关注的问题进行深入讨论。生动的领先文章提供了最近的进展和争议的尖锐报道。其他部分包括:国际评论讨论有争议的问题和想法抗菌实践文章实际处方和规定的问题对应部分科学家提出的早期观察他们的工作和评论文章发表书评有用的评论相关新出版的头衔精心组织格式指引你感兴趣的领域。每月一期可包含多达10个信息性部分:主要文章评论Garrod演讲辩论原始文章摘要报告抗菌实践会议报告通信书评杂志每年出版2至8个增刊。这些包括英国抗微生物药物化疗学会的工作组报告和关于正在开发的药物的临床前和临床方面的原始出版物，或已建立的药物在特定治疗领域的作用。

投稿网址：http://mc.manuscriptcentral.com/oup/jac

英文简介

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia industry and health services and includes those who are influential in formulary decisions. Published monthly the Journal features original articles on the laboratory aspects and clinical use of antimicrobials including antibacterial antiviral antifungal and antiprotozoal agents. In addition to the wealth of primary papers the journal carries review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies. Other sections include: For debate International comment on contentious issues and ideas Antimicrobial practice Articles on practical prescribing and formulary issues Correspondence A section for scientists to present early observations of their work and to comment on published articles Book reviews Helpful reviews of relevant newly published titles A carefully organised format directs you to areas of interest. Monthly issues can include up to ten informative sections: Leading articles Reviews The Garrod Lecture For debate Original articles Brief reports Antimicrobial practice Meeting reports Correspondence Book reviews The Journal publishes between two and eight supplements each year. These include Working Party reports of the British Society for Antimicrobial Chemotherapy and original publications on pre-clinical and clinical aspects of drugs in development or the role of established drugs in specific therapeutic areas.